MLKL deficiency protects against low-grade, sterile inflammation in aged mice
Details
Publication Year 2023-02-08,Volume 30,Issue #4,Page 1059-1071
Journal Title
Cell Death & Differentiation
Abstract
MLKL and RIPK3 are the core signaling proteins of the inflammatory cell death pathway, necroptosis, which is a known mediator and modifier of human disease. Necroptosis has been implicated in the progression of disease in almost every physiological system and recent reports suggest a role for necroptosis in aging. Here, we present the first comprehensive analysis of age-related histopathological and immunological phenotypes in a cohort of Mlkl(-/-) and Ripk3(-/-) mice on a congenic C57BL/6 J genetic background. We show that genetic deletion of Mlkl in female mice interrupts immune system aging, specifically delaying the age-related reduction of circulating lymphocytes. -Seventeen-month-old Mlkl(-/-) female mice were also protected against age-related chronic sterile inflammation in connective tissue and skeletal muscle relative to wild-type littermate controls, exhibiting a reduced number of immune cell infiltrates in these sites and fewer regenerating myocytes. These observations implicate MLKL in age-related sterile inflammation, suggesting a possible application for long-term anti-necroptotic therapy in humans.
Publisher
NPG
Research Division(s)
Inflammation; Bioinformatics; Ubiquitin Signalling; Blood Cells And Blood Cancer
PubMed ID
36755069
Open Access at Publisher's Site
https://doi.org/10.1038/s41418-023-01121-4
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2023-03-17 11:09:18
Last Modified: 2023-04-12 09:44:17
An error has occurred. This application may no longer respond until reloaded. Reload 🗙